This multibagger pharma stock is down 10% from record high—CFO reveals growth plan
Hyderabad-based pharma and biotech firm Sai Life Sciences, which offers contract research, development, and manufacturing services to large pharma firms, has seen its stock more than double in less than two years since listing. After hitting a record high of ₹1,697 in early September, the stock has…